295 related articles for article (PubMed ID: 33946652)
1. The Role of LGR4 (GPR48) in Normal and Cancer Processes.
Ordaz-Ramos A; Rosales-Gallegos VH; Melendez-Zajgla J; Maldonado V; Vazquez-Santillan K
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946652
[TBL] [Abstract][Full Text] [Related]
2. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.
Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M
FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400
[TBL] [Abstract][Full Text] [Related]
3. LGR4, a G Protein-Coupled Receptor With a Systemic Role: From Development to Metabolic Regulation.
Filipowska J; Kondegowda NG; Leon-Rivera N; Dhawan S; Vasavada RC
Front Endocrinol (Lausanne); 2022; 13():867001. PubMed ID: 35707461
[TBL] [Abstract][Full Text] [Related]
4. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling.
Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B
EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406
[TBL] [Abstract][Full Text] [Related]
5. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling.
Carmon KS; Gong X; Lin Q; Thomas A; Liu Q
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11452-7. PubMed ID: 21693646
[TBL] [Abstract][Full Text] [Related]
6. RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.
Carmon KS; Gong X; Yi J; Thomas A; Liu Q
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1221-9. PubMed ID: 24639526
[TBL] [Abstract][Full Text] [Related]
7. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins.
van Andel H; Ren Z; Koopmans I; Joosten SP; Kocemba KA; de Lau W; Kersten MJ; de Bruin AM; Guikema JE; Clevers H; Spaargaren M; Pals ST
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):376-381. PubMed ID: 28028233
[TBL] [Abstract][Full Text] [Related]
8. Lgr4 is crucial for skin carcinogenesis by regulating MEK/ERK and Wnt/β-catenin signaling pathways.
Xu P; Dang Y; Wang L; Liu X; Ren X; Gu J; Liu M; Dai X; Ye X
Cancer Lett; 2016 Dec; 383(2):161-170. PubMed ID: 27693558
[TBL] [Abstract][Full Text] [Related]
9. Differential activities and mechanisms of the four R-spondins in potentiating Wnt/β-catenin signaling.
Park S; Cui J; Yu W; Wu L; Carmon KS; Liu QJ
J Biol Chem; 2018 Jun; 293(25):9759-9769. PubMed ID: 29752411
[TBL] [Abstract][Full Text] [Related]
10. Unlike LGR4, LGR5 potentiates Wnt-β-catenin signaling without sequestering E3 ligases.
Park S; Wu L; Tu J; Yu W; Toh Y; Carmon KS; Liu QJ
Sci Signal; 2020 Dec; 13(660):. PubMed ID: 33262293
[No Abstract] [Full Text] [Related]
11. Multi-functional norrin is a ligand for the LGR4 receptor.
Deng C; Reddy P; Cheng Y; Luo CW; Hsiao CL; Hsueh AJ
J Cell Sci; 2013 May; 126(Pt 9):2060-8. PubMed ID: 23444378
[TBL] [Abstract][Full Text] [Related]
12. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.
Luo J; Yang Z; Ma Y; Yue Z; Lin H; Qu G; Huang J; Dai W; Li C; Zheng C; Xu L; Chen H; Wang J; Li D; Siwko S; Penninger JM; Ning G; Xiao J; Liu M
Nat Med; 2016 May; 22(5):539-46. PubMed ID: 27064449
[TBL] [Abstract][Full Text] [Related]
13. Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2.
Wang Y; Dong J; Li D; Lai L; Siwko S; Li Y; Liu M
Stem Cells; 2013 Sep; 31(9):1921-31. PubMed ID: 23712846
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of LGR4-Rspo1 complex: insights into the divergent mechanisms of ligand recognition by leucine-rich repeat G-protein-coupled receptors (LGRs).
Xu JG; Huang C; Yang Z; Jin M; Fu P; Zhang N; Luo J; Li D; Liu M; Zhou Y; Zhu Y
J Biol Chem; 2015 Jan; 290(4):2455-65. PubMed ID: 25480784
[TBL] [Abstract][Full Text] [Related]
15. The role of R-spondins and their receptors in bone metabolism.
Shi GX; Mao WW; Zheng XF; Jiang LS
Prog Biophys Mol Biol; 2016 Nov; 122(2):93-100. PubMed ID: 27237581
[TBL] [Abstract][Full Text] [Related]
16. Effect of LGR4/EGFR signaling on cell growth and cancer stem cell-like characteristics in liver cancer.
Liu Y; Zhang Y; Chen S; Zhong X; Liu Q
Cytokine; 2023 May; 165():156185. PubMed ID: 37001327
[TBL] [Abstract][Full Text] [Related]
17. LGR4 maintains HGSOC cell epithelial phenotype and stem-like traits.
Wang Z; Yin P; Sun Y; Na L; Gao J; Wang W; Zhao C
Gynecol Oncol; 2020 Dec; 159(3):839-849. PubMed ID: 32980127
[TBL] [Abstract][Full Text] [Related]
18. LGR4 and Its Role in Intestinal Protection and Energy Metabolism.
Li Z; Zhang W; Mulholland MW
Front Endocrinol (Lausanne); 2015; 6():131. PubMed ID: 26379625
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of RSPO2-GPR48/LGR4 signaling in papillary thyroid carcinoma contributes to tumor progression.
Kang YE; Kim JM; Kim KS; Chang JY; Jung M; Lee J; Yi S; Kim HW; Kim JT; Lee K; Choi MJ; Kang SK; Lee SE; Yi HS; Koo BS; Shong M
Oncotarget; 2017 Dec; 8(70):114980-114994. PubMed ID: 29383135
[TBL] [Abstract][Full Text] [Related]
20. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
